Biogen Inc. buy Needham & Company LLC
Start price
24.04.24
/
50%
€192.85
Target price
24.04.25
€275.07
Performance (%)
-12.29%
Price
22:26
€169.15
Summary
This prediction is currently active. The prediction for Biogen Inc. disappoints with a performance of -12.29%. This prediction currently runs until 24.04.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -3.523% | -3.523% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $294.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat